GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SyntekaBio Inc (XKRX:226330) » Definitions » Deferred Policy Acquisition Costs

SyntekaBio (XKRX:226330) Deferred Policy Acquisition Costs


View and export this data going back to 2019. Start your Free Trial

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


SyntekaBio (XKRX:226330) Business Description

Traded in Other Exchanges
N/A
Address
187, Techno 2-ro, Yuseong-gu, Bi-dong, Yongsan-dong, Megan Techno World 2nd, Daejeon, KOR, 512
SyntekaBio Inc is a bioinformatics venture firm. It is engaged in gene-related research, technology development, and genetic analysis based on the genome big data platform and artificial intelligence deep learning drug development platform. The company manages and analyzes genome analysis and massive biodata and genome.